JPRN-UMIN000016580已完成1 期
Sirolimus for the treatment of lymphangiomatosis, Gorham-Stout disease and vascular anomalies - Sirolimus for vascular anomalies
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 30years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Allergy of sirolimus
研究者
相似试验
已完成
不适用
Sirolimus for the treatment of refractory lymphangiomatosis/ Gorham Stout diseaseJPRN-UMIN000029843Kyushu University Hospital2
已完成
1 期
Everolimus for the treatment of lymphangiomatosis, Gorham-Stout disease and vascular anomaliesymphangiomatosis, Gorham-Stout disease and vascular anomaliesJPRN-UMIN000014888Gifu university30
已完成
2 期
TOPical sirolimus in linGUal microkystic lymphatic malformation2024-515955-39-01Centre Hospitalier Regional Universitaire De Tours12
招募中
不适用
Efficacy and safety of low dose sirolimus in lymphangioleiomyomatosislymphangioleiomyomatosisJPRN-UMIN000016677ational Hospital Organization Kinki-chuo Chest Medical Center20
已完成
3 期
Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial)JPRN-jRCT2091220011Frank McCormack, M.D., University of Cincinnati Medical Center Director, Division of Pulmonary and Critical Care Medicine120